Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition.
Abou Assi L, Alkhansa S, Njeim R, Ismail J, Madi M, Ghadieh HE, Al Moussawi S, Azar TS, Ayoub M, Azar WS, Hamade S, Nawfal R, Haddad NR, Harb F, Faour W, Khalil MI, Eid AA. Abou Assi L, et al. Among authors: harb f. Pharmaceutics. 2024 Jul 19;16(7):955. doi: 10.3390/pharmaceutics16070955. Pharmaceutics. 2024. PMID: 39065652 Free PMC article.
Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes.
Ammar LA, Nahlawi MI, Shayya NW, Ghadieh HE, Azar NS, Harb F, Eid AA. Ammar LA, et al. Among authors: harb f. Front Cardiovasc Med. 2021 Jan 28;7:630917. doi: 10.3389/fcvm.2020.630917. eCollection 2020. Front Cardiovasc Med. 2021. PMID: 33585587 Free PMC article. Review.
Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer.
Mroueh FM, Noureldein M, Zeidan YH, Boutary S, Irani SAM, Eid S, Haddad M, Barakat R, Harb F, Costantine J, Kanj R, Sauleau EA, Ouhtit A, Azar ST, Eid AH, Eid AA. Mroueh FM, et al. Among authors: harb f. FASEB J. 2019 Dec;33(12):14051-14066. doi: 10.1096/fj.201900396RR. Epub 2019 Oct 29. FASEB J. 2019. PMID: 31661292
Modulating this pathway may be a strategic target of therapeutic potential aimed at reversing or slowing the progression of CRC in patients with or without diabetes.-Mroueh, F. M., Noureldein, M., Zeidan, Y. H., Boutary, S., Irani, S. A. M., Eid, S., Haddad, M., Barakat, R …
Modulating this pathway may be a strategic target of therapeutic potential aimed at reversing or slowing the progression of CRC in patients …
44 results